Blockade of noradrenaline re-uptake sites improves accuracy and impulse control in rats performing a five-choice serial reaction time tasks

Psychopharmacology

Volumn 219, Issue 2, 2012, Pages 303-312

  Robinson, Emma S J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

ADHD; Atomoxetine; Attention; Catecholamines; Five choice serial reaction time task; Impulsivity; Methylphenidate; Noradrenaline re uptake; Rat; Reboxetine

Indexed keywords

ATOMOXETINE; METHYLPHENIDATE; NORADRENALIN TRANSPORTER; REBOXETINE;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR CONTROL; CATECHOLAMINE UPTAKE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; FIVE CHOICE SERIAL REACTION TIME TASK; IMPULSIVENESS; LATENT PERIOD; MALE; MENTAL TASK; NEUROPHARMACOLOGY; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RAT; TASK PERFORMANCE;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANIMALS, OUTBRED STRAINS; ATTENTION; CHOICE BEHAVIOR; DOSE-RESPONSE RELATIONSHIP, DRUG; IMPULSIVE BEHAVIOR; MALE; METHYLPHENIDATE; MORPHOLINES; PROPYLAMINES; RATS; REACTION TIME; SERIAL LEARNING; TIME FACTORS;

EID: 84856678937     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2420-3     Document Type: Article

References (50)

1. AF Arnsten 2009 Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction CNS Drugs 23 Suppl 1 33 41 19621976 10.2165/00023210-200923000-00005 1:CAS:528:DC%2BD1MXhtVGit7%2FL
2. TW Robbins AF Arnsten 2009 The neuropsychopharmacology of fronto-executive function: monoaminergic modulation Annu Rev Neurosci 32 267 287 19555290 10.1146/annurev.neuro.051508.135535 1:CAS:528:DC%2BD1MXpsV2nu7w%3D
3. AF Arnsten 2006 Stimulants: therapeutic actions in ADHD Neuropsychopharmacology 31 2376 2383 16855530 10.1038/sj.npp.1301164 1:CAS:528:DC%2BD28XhtVyktLjP (Pubitemid 44607054)
4. TE Wilens 2006 Mechanism of action of agents used in attention-deficit/ hyperactivity disorder J Clin Psychiatry 67 Suppl 8 32 38 16961428 1:CAS:528:DC%2BD28XpsFeis78%3D
5. AF Arnsten L Scahill RL Findling 2007 alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data J Child Adolesc Psychopharmacol 17 393 406 17822336 10.1089/cap.2006.0098
6. CJ Kratochvil BS Vaughan MJ Harrington WJ Burke 2003 Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder Expert Opin Pharmacother 4 1165 1174 12831341 10.1517/14656566.4.7.1165 1:CAS:528:DC%2BD3sXkvFegt70%3D (Pubitemid 36857196)
7. CJ Kratochvil TE Wilens LL Greenhill H Gao KD Baker PD Feldman, et al. 2006 Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder J Am Acad Child Adolesc Psychiatry 45 919 927 16865034 10.1097/01.chi.0000222788.34229.68 (Pubitemid 44126866)
8. B Vaughan J Fegert CJ Kratochvil 2009 Update on atomoxetine in the treatment of attention-deficit/hyperactivity disorder Expert Opin Pharmacother 10 669 676 19239401 10.1517/14656560902762873 1:CAS:528:DC%2BD1MXjtF2murw%3D
9. F Arabgol L Panaghi P Hebrani 2009 Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder Eur Child Adolesc Psychiatry 18 53 59 18563471 10.1007/s00787-008-0705- 9
10. AF Arnsten BM Li 2005 Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions Biol Psychiatry 57 1377 1384 15950011 10.1016/j.biopsych.2004.08.019 1:CAS:528:DC%2BD2MXltFSrs74%3D (Pubitemid 40798558)
11. SV Faraone E Mick 2010 Molecular genetics of attention deficit hyperactivity disorder Psychiatr Clin North Am. 33 159 180 20159345 10.1016/j.psc.2009.12.004
12. AF Arnsten AG Dudley 2005 Methylphenidate improves prefrontal cortical cognitive function through alpha2-adrenoceptor and DA D1 receptor actions: relevance to therapeutic effects in attention deficit hyperactivity disorder Behav Brain Func 1 2 10.1186/1744-9081-1-2 (Pubitemid 44848793)
13. G Tripp JR Wickens 2009 Neurobiology of ADHD Neuropharmacology 57 579 589 19627998 10.1016/j.neuropharm.2009.07.026 1:CAS:528:DC%2BD1MXhtlCgtL%2FJ
14. P Curatolo C Paloscia E D'Agati R Moavero A Pasini 2009 The neurobiology of attention deficit/hyperactivity disorder Eur J Paediatr Neurol 13 299 304 18644740 10.1016/j.ejpn.2008.06.003
15. CW Berridge DM Devilbiss ME Andrzejewski AF Arnsten AE Kelley B Schmeichel, et al. 2006 Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function Biol Psychiatry 60 1111 1120 16806100 10.1016/j.biopsych. 2006.04.022 1:CAS:528:DC%2BD28XhtFKmtLnO (Pubitemid 44647216)
16. DM Devilbiss CW Berridge 2006 Low-dose methylphenidate actions on tonic and phasic locus coeruleus discharge J Pharmacol Exp Ther 319 1327 1335 16980569 10.1124/jpet.106.110015 1:CAS:528:DC%2BD28Xht1yltL3E
17. DM Devilbiss CW Berridge 2008 Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness Biol Psychiatry 64 626 635 18585681 10.1016/j.biopsych.2008.04. 037 1:CAS:528:DC%2BD1cXhtVymtr3O
18. FP Bymaster JS Katner DL Nelson SK Hemrick-Luecke PG Threlkeld JH Heiligenstein, et al. 2002 Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder Neuropsychopharmacol 27 699 711 10.1016/S0893-133X(02)00346-9 1:CAS:528:DC%2BD38Xoslyitb8%3D (Pubitemid 35335888)
19. CJ Swanson KW Perry S Koch-Krueger J Katner KA Svensson FP Bymaster 2006 Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat Neuropharmacol 50 755 760 10.1016/j.neuropharm.2005.11.022 1:CAS:528:DC%2BD28Xjs1Kmtb4%3D
20. E Carboni A Silvagni 2004 Dopamine reuptake by norepinephrine neurons: exception or rule? Crit Rev Neurobiol 16 121 128 15581407 10.1615/ CritRevNeurobiol.v16.i12.130 1:CAS:528:DC%2BD2cXhtVGjsLzL (Pubitemid 39586910)
21. SR Chamberlain U Muller AD Blackwell L Clark TW Robbins BJ Sahakian 2006 Neurochemical modulation of response inhibition and probabilistic learning in humans Science 311 861 863 16469930 10.1126/science.1121218 1:CAS:528: DC%2BD28XhtFyltr4%3D (Pubitemid 43228852)
22. ES Robinson DM Eagle AC Mar A Bari G Banerjee X Jiang, et al. 2008 Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat Neuropsychopharmacology 33 1028 1037 17637611 10.1038/sj.npp.1301487 1:CAS:528:DC%2BD1cXjtFOhtLk%3D (Pubitemid 351367544)
23. A Bari DM Eagle AC Mar ES Robinson TW Robbins 2009 Dissociable effects of NA, DA, and serotonin uptake blockade on stop task performance in rats Psychopharmacology (Berl) 205 273 283 10.1007/s00213-009-1537-0 1:CAS:528:DC%2BD1MXltFymtLw%3D
24. C Blondeau F Dellu-Hagedorn 2007 Dimensional analysis of ADHD subtypes in rats Biol Psychiatry 61 1340 1350 17054922 10.1016/j.biopsych.2006.06.030 (Pubitemid 46855765)
25. R Navarra R Graf Y Huang S Logue T Comery Z Hughes, et al. 2008 Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test Prog Neuropsychopharmacol Biol Psychiatry 32 34 41 17714843 10.1016/j.pnpbp.2007.06.017 1:CAS:528:DC%2BD1cXptlaitg%3D%3D
26. I Tsutsui-Kimura Y Ohmura T Izumi T Yamaguchi T Yoshida M Yoshioka 2009 The effects of serotonin and/or noradrenaline reuptake inhibitors on impulsive-like action assessed by the three-choice serial reaction time task: a simple and valid model of impulsive action using rats Behav Pharmacol 20 474 483 19730368 10.1097/FBP.0b013e3283305e65 1:CAS:528:DC%2BD1MXhtV2qtr%2FE
27. SB Floresco JD Jentsch 2011 Pharmacological enhancement of memory and executive functioning in laboratory animals Neuropsychopharmacology 36 227 250 20844477 10.1038/npp.2010.158 1:CAS:528:DC%2BC3cXhsV2gtb%2FL
28. TW Robbins 2002 The 5-choice serial reaction time task: behavioral pharmacology and functional neurochemistry Psychopharmacology 163 362 380 12373437 10.1007/s00213-002-1154-7 1:CAS:528:DC%2BD38XnsFymurc%3D
29. JA Milstein JW Dalley TW Robbins 2010 Methylphenidate-induced impulsivity: pharmacological antagonism by beta-adrenoreceptor blockade J Psychopharmacol 24 309 321 19074531 10.1177/0269881108098146 1:CAS:528:DC%2BC3cXkslSgtbc%3D
30. JW Dalley RN Cardinal TW Robbins 2004 Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates Neurosci Biobehav Rev 28 771 784 15555683 10.1016/j.neubiorev.2004.09.006 1:CAS:528:DC%2BD2cXhtVSlurnJ (Pubitemid 39535871)
31. SR Chamberlain U Müller TW Robbins BJ Sahakian 2006 Neuropharmacological modulation of cognition Curr Opin Neurol 19 607 612 17102701 10.1097/01.wco.0000247613.28859.77 1:CAS:528:DC%2BD2sXlslSjtg%3D%3D (Pubitemid 44760446)
32. G Aston-Jones JD Cohen 2005 An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance Annu Rev Neurosci 28 403 450 16022602 10.1146/annurev.neuro.28.061604.135709 1:CAS:528:DC%2BD2MXosVegtbw%3D (Pubitemid 41098911)
33. YP Liu YL Lin CH Chuang YC Kao ST Chang CS Tung 2009 Alpha adrenergic modulation on effects of norepinephrine transporter inhibitor reboxetine in five-choice serial reaction time task J Biomed Sci 16 72 76 19678962 10.1186/1423-0127-16-72
34. T Puumala S Ruotsalainen P Jäkälä E Koivisto P Riekkinen Jr J Sirviö 1996 Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder Neurobiol Learn Mem. 66 198 211 8946412 10.1006/nlme.1996.0060 1:CAS:528: DyaK2sXisVWmtg%3D%3D (Pubitemid 26423879)
35. BK Yamamoto S Novotney 1998 Regulation of extracellular dopamine by the norepinephrine transporter J Neurochem 71 274 280 9648875 10.1046/j.1471-4159. 1998.71010274.x 1:CAS:528:DyaK1cXktFamsbg%3D (Pubitemid 28292559)
36. L Bizarro S Patel C Murtagh IP Stolerman 2004 Differential effects of psychomotor stimulants on attentional performance in rats: nicotine, amphetamine, caffeine and methylphenidate Behav Pharmacol 15 195 206 15187577 1:CAS:528:DC%2BD2cXks1Khtbo%3D (Pubitemid 38859602)
37. M Carli TW Robbins JL Evenden BJ Everitt 1983 Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal Behav Brain Res 9 361 380 6639741 10.1016/0166-4328(83)90138-9 1:STN:280:DyaL2c%2Flt1ygtA%3D%3D (Pubitemid 13002330)
38. JA Milstein O Lehmann DE Theobald JW Dalley TW Robbins 2007 Selective depletion of cortical noradrenaline by anti-dopamine beta-hydroxylase-saporin impairs attentional function and enhances the effects of guanfacine in the rat Psychopharmacology 190 51 63 17096085 10.1007/s00213-006-0594-x 1:CAS:528:DC%2BD28Xht1KmtrbF (Pubitemid 44885343)
39. S Bouret SJ Sara 2005 Network reset: a simplified overarching theory of locus coeruleus noradrenaline function Trends Neurosci 28 574 582 16165227 10.1016/j.tins.2005.09.002 1:CAS:528:DC%2BD2MXhtFektbvJ (Pubitemid 41476687)
40. TW Robbins AC Roberts 2007 Differential regulation of fronto-executive function by the monoamines and acetylcholine Cereb Cortex 17 Suppl 1 151 160 10.1093/cercor/bhm066
41. AA Kehagia GK Murray TW Robbins 2010 Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation Curr Opin Neurobiol 20 199 204 20167474 10.1016/j.conb.2010.01.007 1:CAS:528:DC%2BC3cXlsFCisr0%3D
42. JW Dalley J McGaughy MT O'Connell RN Cardinal L Levita TW Robbins 2001 Distinct changes in cortical acetylcholine and noradrenaline efflux during contingent and noncontingent performance of a visual attentional task J Neurosci 21 4908 4914 11425918 1:CAS:528:DC%2BD3MXks1akt70%3D (Pubitemid 32565649)
43. DS Tait VJ Brown A Farovik DE Theobald JW Dalley TW Robbins 2007 Lesions of the dorsal noradrenergic bundle impair attentional set-shifting in the rat Eur J Neurosci 25 3719 3724 17610591 10.1111/j.1460-9568.2007.05612.x (Pubitemid 47020451)
44. RD Oades AG Sadile T Sagvolden D Viggiano A Zuddas P Devoto H Aase EB Johansen LA Ruocco VA Russell 2005 The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles Dev Sci 8 122 131 15720370 10.1111/j.1467-7687.2005.00399.x (Pubitemid 40350166)
45. MN Koffarnus JL Katz 2011 Response requirement and increases in accuracy produced by stimulant drugs in a 5-choice serial reaction-time task in rats Psychopharmacology 213 723 733 20924752 10.1007/s00213-010-2027-0 1:CAS:528:DC%2BC3cXht1Cns7jM
46. Y Chudasama F Passetti SE Rhodes D Lopian A Desai TW Robbins 2003 Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: differential effects on selectivity, impulsivity and compulsivity Behav Brain Res 146 105 119 14643464 10.1016/j.bbr.2003.09.020 1:STN:280:DC%2BD3srmsFShsg%3D%3D (Pubitemid 37476138)
47. S Granon F Passetti KL Thomas JW Dalley BJ Everitt TW Robbins 2000 Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex J Neurosci 20 1208 1215 10648725 1:CAS:528:DC%2BD3cXhtFGquro%3D (Pubitemid 30220477)
48. NJ Gamo M Wang AF Arnsten 2010 Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors J Am Acad Child Adolesc Psychiatry 49 1011 1023 20855046 10.1016/j.jaac.2010.06.015
49. BJ Cole TW Robbins 1989 Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal Behav Brain Res 33 165 179 2504222 10.1016/S0166-4328(89)80048-8 1:STN:280: DyaL1MzltFOrsQ%3D%3D (Pubitemid 19141065)
50. JM Delfs Y Zhu JP Druhan GS Aston-Jones 1998 Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat Brain Res 806 127 140 9739125 10.1016/S0006-8993(98)00672-6 1:CAS:528:DyaK1cXlsl2nsrY%3D (Pubitemid 29010488)